Last reviewed · How we verify
NCT04110015: proVVF
Assessment of Visual Function in Ophthalmic Disorders Using Virtual Visual Field Analysis
trial testing virtual visual field in Visual Pathway Disorder in 120 participants. Terminated before completion.
30 October 2020
Quick facts
| Lead sponsor | New York City Health and Hospitals Corporation |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 120 |
| Start date | 1 October 2020 |
| Primary completion | 30 October 2020 |
| Estimated completion | 23 August 2021 |
| Sites | 1 location across United States |
Drugs / interventions tested
- virtual visual field
Conditions studied
- Visual Pathway Disorder — all drugs for Visual Pathway Disorder →
- Glaucoma — all drugs for Glaucoma →
- Retinal Disease — all drugs for Retinal Disease →
Sponsor
New York City Health and Hospitals Corporation
Who can join
18 and older, any sex, with Visual Pathway Disorder or Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
1. To evaluate the accuracy of virtual visual field (VVF) headsets equipped the standard visual field software in its ability to assess visual function in various retinal, glaucoma and neuro-ophthalmic disorders by comparing retinal fundus and optic nerve images, optical coherence tomography and neuroimages to the VVF produced. 2. To test the null hypothesis that VVF testing compares favorably to the gold standard, Humphrey visual field (HVF) by comparing testing time, mean sensitivity, markers of reliability including false positives and negatives and fixation losses and global indices such as mean deviation and pattern standard deviation.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04110015
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other New York City Health and Hospitals Corporation trials
Trials by the same sponsor.
- NCT06981650 — Video Education to Improve First Time Colonoscopy Outcomes · NA · not yet recruiting
- NCT04630834 — Ibuprofen Plus Acetaminophen for Enhanced Pain Reduction · Phase 4 · unknown
- NCT04313179 — Music Therapy for Pain Management for Minor Procedures in Neonates. · NA · terminated
- NCT03619746 — Point-of-Care Ultrasound Educational Initiative for Insect Bites · NA · terminated
- NCT03340740 — The Effect of Cetirizine on Bronchoconstriction · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04110015 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by New York City Health and Hospitals Corporation
- Last refreshed: 30 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04110015.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing